CEACAM5 and neoplasm: In addition, 6 clinical classic tumor biomarkers, including CA12-5, CA19-9, CEA, CYFRA21-1, NSE, and squamous cell carcinoma antigen (SCC), were selected to be evaluated and integrated for establishing screening and diagnostic models.